Biocare: The GLP-1 Shake Built for Side Effects, Not Just Protein
Every protein powder on this site solves the "not enough protein" problem. Biocare is built to solve a different one: the nausea, bloating, and fatigue that make eating protein — or eating anything — hard in the first place. It comes from Robard Corporation, a company that's worked in medically-guided weight management since 1976, which is a different pedigree than most of the GLP-1-branded products that have shown up in just the last year or two.
What makes the formula different
30g of protein per serving (a whey concentrate/isolate blend) plus 26 vitamins and minerals dosed at elevated levels specifically for GLP-1 users who are eating much less overall. The part that's actually unusual is a patent-pending digestive complex — GutGard, DigeZyme, and PepZinGI — three ingredients aimed directly at the nausea, bloating, and fatigue that are the most common complaints in this entire niche. Most protein powders don't touch this at all; they assume you can already eat comfortably.
Price and dosing
$55.90 for a 14-serving box — on the expensive end for a protein shake, priced closer to a specialty medical-nutrition product than a standard supplement. Robard recommends 2 servings a day for people actively on GLP-1 medications.
Worth knowing
Real user feedback is mixed on taste and mouthfeel — some describe it as sweet or a bit chalky when blended — and at $4/serving, it's genuinely one of the pricier options in this category. The honest trade-off is that you're paying for the digestive-support ingredients and the dosing designed around reduced food intake, not just for protein grams; if you're not struggling with GI side effects, a plain protein shake delivers more protein per dollar.
See our guide on getting enough protein when nausea makes eating hard for where this fits into a broader first-90-days strategy, or our protein powder comparison for the muscle-preservation-focused pick. If you're reducing or stopping your medication, see what comes next, including the transition-phase Biocare2.